Inhibitors of phosphoinositide-specific phospholipase C
US5519163A · kind A · utility
14Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 15, 1993 |
| Grant date | May 21, 1996 |
| Priority date | — |
| Expiry date | Oct 15, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/3882
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel .alpha.-hydroxyphosphonate compounds which inhibit mammalian phosphoinositide-specific phospholipase-C. The compounds are potent anti-inflammatory and analgesic agents and may be useful for the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.